Navigation Links
Sosei in Medical News

Sosei Announces Start of AD 923 Phase III Studies in Europe

...OKYO, Japan, February 12 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...safety and tolerability of AD 923. In June 2006, sosei entered into an agreement with Mundipharma Interna...tional markets, excluding North America and Japan. sosei is currently evaluating its commercialisation opti...

Sosei Announces Approval to Start AD 923 Phase III Studies in Europe

... TOKYO, November 28 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...in the trial". Notes to Editors: About Sosei sosei Group Corporation is a leading international bioph...ckout system that prevents inadvertent overdosing. sosei has concluded a range of studies that confirm the ...

Sosei Announces Update on Phase I Trials for SD118

... TOKYO, November 27 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...ction that lead to improved drugs. About Sosei sosei Group Corporation is a leading international bioph...s on its lead compound NSL-043 in partnership with sosei Group Corporation, a listed Japanese biopharmaceut...

Sosei and Vectura Announce Start of Phase II Studies of QVA149 for the Treatment of COPD

...AM, England, November 15 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...o severe COPD. NVA237 was licensed to Novartis by sosei and Vectura in 2005 in a deal in which the two com... About the NVA237 licence agreement with Novartis sosei and its co-development partner Vectura Group plc c...
Sosei in Medical Technology

Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237

...riggers $7.5m Milestones for Both Companies sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...l trigger a $7.5 million milestone payment to both sosei and Vectura. The trial is a randomised, dou... NVA237 was licensed to Novartis in April 2005 by sosei and its co-development partner Vectura. Novartis i...

Sosei Confirms the Safety of SD118 in Two Phase I Trials

... TOKYO, December 8 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...esia A reduced sense of touch. About sosei sosei Group is a leading international biopharmaceutical...

Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting

...service provider and drug development Company, and sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...nflammatory pain." Mr Shinichi Tamura, CEO sosei Group added: "We are pleased to have collaborated ...opment compound NSL-043/SD118, in partnership with sosei Co. Ltd. Both of these trials reported a successfu...

NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium

...lar findings. NVA237 was licensed to Novartis by sosei and Vectura in 2005 in a deal in which the two com...VA237 and QVA149 licence agreement with Novartis sosei and Vectura Group plc concluded a global developme...st, as QVA149. Under the terms of the agreement, sosei and Vectura to date have each received $15 million...

Sosei Announces Completion of Phase III Trial for NorLevo(R)

... TOKYO, July 10 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...ncy contraceptive pill (ECP) SOH-075 (NorLevo(R)). sosei acquired the exclusive distribution rights to the ...d as an essential drug by the WHO. About Sosei sosei Group is a leading international biopharmaceutical...

Sosei Announces Successful Completion of AD 923 Pharmacokinetic Study in the USA

... TOKYO, May 22, 2007 /PRNewswire-FirstCall/ -- sosei Group Corporation , a biopharmaceutical company, t...with no significant safety issues identified. sosei has reached agreement with EU regulatory authoriti...o Phase III studies." Notes for Editors: About sosei ...
Sosei in Biological Technology

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...icenses Antibody-Drug Conjugates Development Rights to Genentech II-88 National Cancer Institute Enters into Agreement with Illumina II-89 sosei Seeks Marketing Rights for Prostate Cancer Drug in Japan II-89 8. Focus on Select Global Players II-90 Abbott Laboratories (USA) II-90 Ae...

Sosei Announces the Out-licensing of RS(+) Mefloquine to Treague Ltd for the Treatment and Prophylaxis of Malaria

... Based on its cytokine modulatory activity, sosei were developing RS(+) mefloquine as AD 452 for the...es over existing treatment options." About sosei sosei Group is a leading international biopharmaceutical...

Sosei Agrees Terms With ASKA for Commercialisation of SOH-075 (NorLevo(R))

... TOKYO, October 22 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...he biopharmaceutical company, today announced that sosei Co., Ltd., its wholly owned Japanese subsidiary, h... oral emergency contraceptive for post-coital use. sosei acquired the exclusive distribution rights to the ...

WWMR, Inc. Announces Launch of New Pain Clinic Monitor

...Reckitt Benckiser/Vernalis, Durect, Rinat Neuroscience/Pfizer, Elan Pharm, Roche, Eli Lilly, Sanofi-Aventis, Endo Pharm, Schwarz, Forest Laboratories, sosei R&D, Gedeon Richter, Teikoku Seiyaku, GlaxoSmithKline, TheraQuest, Grunenthal, Vernalis, GW Pharmaceuticals, Watson Pharm, Janssen-Cilag, Wyeth Pharma...

Sosei Announces Outcome of Strategy Review

... TOKYO, May 14 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...ness from NVA237/QVA149 in a few years time. - sosei is closing its Chesterford operation and sosei R&D's continuing business will relocate to London...

Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities

... Prior to Marquant, Joy's positions included: Vice President, Business Development at Nabi Biopharmaceuticals; Vice President, Business Development at sosei Co. Ltd; Commercial Director at Xenova Group Limited; member of the Pharmaceuticals and Medical Products practice at Accenture; and various roles in t...

Sosei Announces Completion of Phase II Trial of AD 337 in Fibromyalgia Syndrome

... TOKYO, September 18 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456... potential indications." Notes to Editors: About sosei sosei Group Corporation is a leading international bioph...
Other Tags
(Date:8/28/2014)... Dallas, TX (PRWEB) August 29, 2014 ... and in-depth study on the current state of the ... provides a basic overview of the industry, including definitions, ... Chinese domestic market analysis are provided with a focus ... market. A comparison between the international and Chinese situation ...
(Date:8/28/2014)... 29, 2014 Top10BestSEOHosting.com has recently ... that FatCow, Hostgator and Bluehost are the best ... ) has been working in the hosting industry ... is connected to multiple GB connections to ensure ... disruptions to customers’ websites. The great thing is ...
(Date:8/28/2014)... August 28, 2014 Millennium Treatment ... throughout September. This month will be a celebration ... mental health services. Along with other treatment facilities ... helping to spread the word about this national ... honoring the work of treatment and recovery professionals, ...
(Date:8/28/2014)... American adults who are beginning to research providers ... have a simpler way to connect with companies using ... some of the best life insurance rates available are ... promoted plans that included price data revealed to adults ... The term, guaranteed and modified plans that might be ...
(Date:8/28/2014)... Chicago (PRWEB) August 28, 2014 ABC ... on the 49th MDA Show of Strength Telethon airing ... the country to help raise funds and awareness to ... adults affected by muscle disease. , Viewers tuning into ... will enjoy heart-felt appeals and introductions from some of ...
Breaking Medicine News(10 mins):Health News:Global Oscilloscope Industry (North America, Europe, Asia, and ROW) Forecast Report 2020 Now Available at ReportsnReports.com 2Health News:Global Oscilloscope Industry (North America, Europe, Asia, and ROW) Forecast Report 2020 Now Available at ReportsnReports.com 3Health News:Best Suppliers of Affordable Hosting Products Introduced by Top10BestSEOHosting.com 2Health News:Millennium Treatment Group Celebrates National Recovery Month 2Health News:Best Life Insurance Rates for 2014 Now Promoted at Insurer Website 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 3Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 4
(Date:8/28/2014)... available in German . ... built with the help of sophisticated assembly lines. Mobile assembly ... important part of these assembly lines. In the case of ... work stages arranged in a precise spatial and chronological sequence, ... line. , The creation of such an assembly line at ...
(Date:8/28/2014)... conserve biodiversity and more action is needed to ensure ... say. , Published in PLOS ONE , researchers ... Exeter, used meta-analysis - combining results from different studies ... research into these areas, to determine whether they actually ... Biological Sciences, said protecting an area from human exploitation ...
(Date:8/27/2014)... Aug. 27, 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) ... underwritten public offering of units of common stock and ... gross proceeds of $20 million, prior to deducting underwriting ... Company.  The shares and warrants are immediately separable and ... sold in the offering consists of 2,000 shares of ...
Breaking Biology News(10 mins):Nanoscale assembly line 2Nanoscale assembly line 3Protected areas proven to protect biodiversity 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 3
Other Contents